Oguzhan Atay

Oguzhan believes that diagnostics can be made much more powerful, accurate, and affordable if they were engineered to be quantitative. At BillionToOne, Oguzhan helped develop a patent-pending molecular counter platform that increases the resolution of molecular diagnostics by over a thousandfold. He has led BillionToOne through Y Combinator and raised a total of 17.5M in funding including from venture capital funds and investors who previously invested in tech companies such as SpaceX, Box, Spotify, Palantir, Braintree, and biotech companies such as Counsyl, WebMD, and Omada Health. Oguzhan received his PhD from Stanford, where his work was published on the Cover of Cell Systems.

Previously, Oguzhan graduated summa cum laude and Phi Beta Kappa from Princeton University with a Bachelor’s in Molecular Biology and minors in Physics, Computer Science, and Applied Mathematics.